The production of chemical and pharmaceutical products in Finland exhibited moderate growth from 2013 to 2019, followed by a significant dip in 2020 due to disruptions likely stemming from the global pandemic. From 2021 onward, the production value rebounded strongly. In 2023, the production value stood at 12.1 billion Euros, showing stability and a slight increase from the previous year. The annual variations over the previous two years were +2.18% in 2023 and -7.02% in 2022. The average annual growth rate over the last five years (2019-2023) was 2.22%, indicating a steady recovery post-pandemic.
Looking forward, the production is forecasted to grow steadily with a projected value of 13.52 billion Euros by 2028. The five-year CAGR (2024-2028) is expected to be 1.63%, reflecting moderate but consistent growth. This trend suggests that the sector will continue to recover and expand, albeit at a slower pace compared to the rebound seen in the immediate post-pandemic years.
Future trends to watch for include:
- Technological advancements and innovation in the pharmaceutical sector.
- Potential impacts of regulatory changes on production capacities and operational efficiencies.
- Shifts in global supply chains affecting the availability and cost of raw materials.
- Increased focus on sustainability and environmentally friendly practices in production processes.
